Global Equine Pharmaceuticals and Supplements Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Equine Pharmaceuticals and Supplements market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1363.7 million by 2025, from USD 1152.1 million in 2019.
The Equine Pharmaceuticals and Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Equine Pharmaceuticals and Supplements market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Equine Pharmaceuticals and Supplements market has been segmented into Pharmaceuticals, Supplements, etc.
By Application, Equine Pharmaceuticals and Supplements has been segmented into Thoroughbred Horse, Other Types of Horses, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Equine Pharmaceuticals and Supplements market presented in the report. This section sheds light on the sales growth of different regional and country-level Equine Pharmaceuticals and Supplements markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Equine Pharmaceuticals and Supplements market.
The report offers in-depth assessment of the growth and other aspects of the Equine Pharmaceuticals and Supplements market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Equine Pharmaceuticals and Supplements markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Equine Pharmaceuticals and Supplements Market Share Analysis
Equine Pharmaceuticals and Supplements competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Equine Pharmaceuticals and Supplements sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Equine Pharmaceuticals and Supplements sales, revenue and market share for each player covered in this report.
The major players covered in Equine Pharmaceuticals and Supplements are: Boehringer Ingelheim, Virbac, Bayer Animal Health, Merck Animal Health, CEVA, Zoetis, Kyoritsu Seiyaku, Dechra Veterinary Products, Elanco Animal Health, Norbrook Equine, Vetoquinol, Ouro Fino Saude, Protexin Healthcare, Audevard, etc. Among other players domestic and global, Equine Pharmaceuticals and Supplements market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Pharmaceuticals and Supplements product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Equine Pharmaceuticals and Supplements, with price, sales, revenue and global market share of Equine Pharmaceuticals and Supplements in 2018 and 2019.
Chapter 3, the Equine Pharmaceuticals and Supplements competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Pharmaceuticals and Supplements breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Equine Pharmaceuticals and Supplements Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Equine Pharmaceuticals and Supplements Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Market Analysis by Application
1.3.1 Overview: Global Equine Pharmaceuticals and Supplements Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Thoroughbred Horse
1.3.3 Other Types of Horses
1.4 Overview of Global Equine Pharmaceuticals and Supplements Market
1.4.1 Global Equine Pharmaceuticals and Supplements Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boehringer Ingelheim SWOT Analysis
2.1.4 Boehringer Ingelheim Product and Services
2.1.5 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Virbac
2.2.1 Virbac Details
2.2.2 Virbac Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Virbac SWOT Analysis
2.2.4 Virbac Product and Services
2.2.5 Virbac Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer Animal Health
2.3.1 Bayer Animal Health Details
2.3.2 Bayer Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer Animal Health SWOT Analysis
2.3.4 Bayer Animal Health Product and Services
2.3.5 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck Animal Health
2.4.1 Merck Animal Health Details
2.4.2 Merck Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck Animal Health SWOT Analysis
2.4.4 Merck Animal Health Product and Services
2.4.5 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 CEVA
2.5.1 CEVA Details
2.5.2 CEVA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CEVA SWOT Analysis
2.5.4 CEVA Product and Services
2.5.5 CEVA Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Zoetis SWOT Analysis
2.6.4 Zoetis Product and Services
2.6.5 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Kyoritsu Seiyaku
2.7.1 Kyoritsu Seiyaku Details
2.7.2 Kyoritsu Seiyaku Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Kyoritsu Seiyaku SWOT Analysis
2.7.4 Kyoritsu Seiyaku Product and Services
2.7.5 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Dechra Veterinary Products
2.8.1 Dechra Veterinary Products Details
2.8.2 Dechra Veterinary Products Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Dechra Veterinary Products SWOT Analysis
2.8.4 Dechra Veterinary Products Product and Services
2.8.5 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Elanco Animal Health
2.9.1 Elanco Animal Health Details
2.9.2 Elanco Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Elanco Animal Health SWOT Analysis
2.9.4 Elanco Animal Health Product and Services
2.9.5 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Norbrook Equine
2.10.1 Norbrook Equine Details
2.10.2 Norbrook Equine Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Norbrook Equine SWOT Analysis
2.10.4 Norbrook Equine Product and Services
2.10.5 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Vetoquinol
2.11.1 Vetoquinol Details
2.11.2 Vetoquinol Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Vetoquinol SWOT Analysis
2.11.4 Vetoquinol Product and Services
2.11.5 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ouro Fino Saude
2.12.1 Ouro Fino Saude Details
2.12.2 Ouro Fino Saude Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ouro Fino Saude SWOT Analysis
2.12.4 Ouro Fino Saude Product and Services
2.12.5 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Protexin Healthcare
2.13.1 Protexin Healthcare Details
2.13.2 Protexin Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Protexin Healthcare SWOT Analysis
2.13.4 Protexin Healthcare Product and Services
2.13.5 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Audevard
2.14.1 Audevard Details
2.14.2 Audevard Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Audevard SWOT Analysis
2.14.4 Audevard Product and Services
2.14.5 Audevard Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2019
3.3.2 Top 6 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Regions
4.1.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Regions (2015-2020)
4.1.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Regions (2015-2020)
4.2 North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
4.3 Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
4.5 South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Country
5.1.1 North America Equine Pharmaceuticals and Supplements Sales and Market Share by Country (2015-2020)
5.1.2 North America Equine Pharmaceuticals and Supplements Revenue and Market Share by Country (2015-2020)
5.2 United States Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5.3 Canada Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
5.4 Mexico Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Country
6.1.1 Europe Equine Pharmaceuticals and Supplements Sales and Market Share by Country (2015-2020)
6.1.2 Europe Equine Pharmaceuticals and Supplements Revenue and Market Share by Country (2015-2020)
6.2 Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.3 UK Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.4 France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.5 Russia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
6.6 Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue and Market Share by Regions (2015-2020)
7.2 China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
7.3 Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
7.4 Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
7.5 India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
7.7 Australia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Country
8.1.1 South America Equine Pharmaceuticals and Supplements Sales and Market Share by Country (2015-2020)
8.1.2 South America Equine Pharmaceuticals and Supplements Revenue and Market Share by Country (2015-2020)
8.2 Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
8.3 Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Equine Pharmaceuticals and Supplements Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
9.3 Turkey Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
9.4 Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
9.5 South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Type (2015-2020)
10.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2015-2020)
10.3 Global Equine Pharmaceuticals and Supplements Price by Type (2015-2020)
11 Global Equine Pharmaceuticals and Supplements Market Segment by Application
11.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)
11.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2015-2020)
11.3 Global Equine Pharmaceuticals and Supplements Price by Application (2015-2020)
12 Market Forecast
12.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2021-2025)
12.2 Equine Pharmaceuticals and Supplements Market Forecast by Regions (2021-2025)
12.2.1 North America Equine Pharmaceuticals and Supplements Market Forecast (2021-2025)
12.2.2 Europe Equine Pharmaceuticals and Supplements Market Forecast (2021-2025)
12.2.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Forecast (2021-2025)
12.2.4 South America Equine Pharmaceuticals and Supplements Market Forecast (2021-2025)
12.2.5 Middle East & Africa Equine Pharmaceuticals and Supplements Market Forecast (2021-2025)
12.3 Equine Pharmaceuticals and Supplements Market Forecast by Type (2021-2025)
12.3.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2021-2025)
12.3.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2021-2025)
12.4 Equine Pharmaceuticals and Supplements Market Forecast by Application (2021-2025)
12.4.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2021-2025)
12.4.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Equine Pharmaceuticals and Supplements Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Equine Pharmaceuticals and Supplements by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Equine Pharmaceuticals and Supplements Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Major Business
Table 9. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 10. Boehringer Ingelheim SWOT Analysis
Table 11. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
Table 12. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Virbac Basic Information, Manufacturing Base and Competitors
Table 14. Virbac Equine Pharmaceuticals and Supplements Major Business
Table 15. Virbac Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 16. Virbac SWOT Analysis
Table 17. Virbac Equine Pharmaceuticals and Supplements Product and Services
Table 18. Virbac Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Animal Health Equine Pharmaceuticals and Supplements Major Business
Table 21. Bayer Animal Health Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 22. Bayer Animal Health SWOT Analysis
Table 23. Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 24. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 26. Merck Animal Health Equine Pharmaceuticals and Supplements Major Business
Table 27. Merck Animal Health Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 28. Merck Animal Health SWOT Analysis
Table 29. Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 30. Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. CEVA Basic Information, Manufacturing Base and Competitors
Table 32. CEVA Equine Pharmaceuticals and Supplements Major Business
Table 33. CEVA Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 34. CEVA SWOT Analysis
Table 35. CEVA Equine Pharmaceuticals and Supplements Product and Services
Table 36. CEVA Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Zoetis Basic Information, Manufacturing Base and Competitors
Table 38. Zoetis Equine Pharmaceuticals and Supplements Major Business
Table 39. Zoetis Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 40. Zoetis SWOT Analysis
Table 41. Zoetis Equine Pharmaceuticals and Supplements Product and Services
Table 42. Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Kyoritsu Seiyaku Basic Information, Manufacturing Base and Competitors
Table 44. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Major Business
Table 45. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 46. Kyoritsu Seiyaku SWOT Analysis
Table 47. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
Table 48. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Dechra Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 50. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Major Business
Table 51. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 52. Dechra Veterinary Products SWOT Analysis
Table 53. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
Table 54. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 56. Elanco Animal Health Equine Pharmaceuticals and Supplements Major Business
Table 57. Elanco Animal Health Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 58. Elanco Animal Health SWOT Analysis
Table 59. Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 60. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Norbrook Equine Basic Information, Manufacturing Base and Competitors
Table 62. Norbrook Equine Equine Pharmaceuticals and Supplements Major Business
Table 63. Norbrook Equine Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 64. Norbrook Equine SWOT Analysis
Table 65. Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
Table 66. Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 68. Vetoquinol Equine Pharmaceuticals and Supplements Major Business
Table 69. Vetoquinol Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 70. Vetoquinol SWOT Analysis
Table 71. Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
Table 72. Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Ouro Fino Saude Basic Information, Manufacturing Base and Competitors
Table 74. Ouro Fino Saude Equine Pharmaceuticals and Supplements Major Business
Table 75. Ouro Fino Saude Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 76. Ouro Fino Saude SWOT Analysis
Table 77. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
Table 78. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Protexin Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Protexin Healthcare Equine Pharmaceuticals and Supplements Major Business
Table 81. Protexin Healthcare Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 82. Protexin Healthcare SWOT Analysis
Table 83. Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
Table 84. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Audevard Basic Information, Manufacturing Base and Competitors
Table 86. Audevard Equine Pharmaceuticals and Supplements Major Business
Table 87. Audevard Equine Pharmaceuticals and Supplements Total Revenue (USD Million) (2017-2018)
Table 88. Audevard SWOT Analysis
Table 89. Audevard Equine Pharmaceuticals and Supplements Product and Services
Table 90. Audevard Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Equine Pharmaceuticals and Supplements Sales by Manufacturer (2018-2019) (K Units)
Table 92. Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Equine Pharmaceuticals and Supplements Sales by Regions (2015-2020) (K Units)
Table 94. Global Equine Pharmaceuticals and Supplements Sales Market Share by Regions (2015-2020)
Table 95. Global Equine Pharmaceuticals and Supplements Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Equine Pharmaceuticals and Supplements Sales by Countries (2015-2020) (K Units)
Table 97. North America Equine Pharmaceuticals and Supplements Sales Market Share by Countries (2015-2020)
Table 98. North America Equine Pharmaceuticals and Supplements Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2015-2020)
Table 100. Europe Equine Pharmaceuticals and Supplements Sales by Countries (2015-2020) (K Units)
Table 101. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Countries (2015-2020)
Table 102. Europe Equine Pharmaceuticals and Supplements Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Regions (2015-2020) (K Units)
Table 104. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Equine Pharmaceuticals and Supplements Sales by Countries (2015-2020) (K Units)
Table 107. South America Equine Pharmaceuticals and Supplements Sales Market Share by Countries (2015-2020)
Table 108. South America Equine Pharmaceuticals and Supplements Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Equine Pharmaceuticals and Supplements Sales by Countries (2015-2020) (K Units)
Table 111. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2015-2020)
Table 114. Global Equine Pharmaceuticals and Supplements Sales by Type (2015-2020) (K Units)
Table 115. Global Equine Pharmaceuticals and Supplements Sales Share by Type (2015-2020)
Table 116. Global Equine Pharmaceuticals and Supplements Revenue by Type (2015-2020) (USD Million)
Table 117. Global Equine Pharmaceuticals and Supplements Revenue Share by Type (2015-2020)
Table 118. Global Equine Pharmaceuticals and Supplements Sales by Application (2015-2020) (K Units)
Table 119. Global Equine Pharmaceuticals and Supplements Sales Share by Application (2015-2020)
Table 120. Global Equine Pharmaceuticals and Supplements Sales Forecast by Regions (2021-2025) (K Units)
Table 121. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Regions (2021-2025)
Table 122. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2021-2025) (K Units)
Table 123. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2021-2025)
Table 124. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2021-2025)
Table 125. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Equine Pharmaceuticals and Supplements Picture
Figure 2. Global Sales Market Share of Equine Pharmaceuticals and Supplements by Type in 2019
Figure 3. Pharmaceuticals Picture
Figure 4. Supplements Picture
Figure 5. Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2018
Figure 6. Thoroughbred Horse Picture
Figure 7. Other Types of Horses Picture
Figure 8. Global Equine Pharmaceuticals and Supplements Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Equine Pharmaceuticals and Supplements Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturer in 2019
Figure 29. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Equine Pharmaceuticals and Supplements Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Equine Pharmaceuticals and Supplements Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Regions (2015-2020)
Figure 36. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Regions in 2018
Figure 37. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
Figure 38. Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
Figure 40. South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020)
Figure 42. North America Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Equine Pharmaceuticals and Supplements Sales Market Share by Countries (2015-2020)
Figure 44. North America Equine Pharmaceuticals and Supplements Sales Market Share by Countries in 2018
Figure 45. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Countries in 2018
Figure 47. United States Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Countries in 2019
Figure 53. Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Regions 2019
Figure 61. China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Equine Pharmaceuticals and Supplements Sales Market Share by Countries in 2019
Figure 68. South America Equine Pharmaceuticals and Supplements Revenue Market Share by Countries in 2019
Figure 69. Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Equine Pharmaceuticals and Supplements Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Equine Pharmaceuticals and Supplements Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Equine Pharmaceuticals and Supplements Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Equine Pharmaceuticals and Supplements Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Equine Pharmaceuticals and Supplements Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Equine Pharmaceuticals and Supplements Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Equine Pharmaceuticals and Supplements Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets